Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
ART3
Entity type
gene
Source
Source Link
Details
PrimaryID
419
RefseqGene
Symbol
ART3
Name
ADP-ribosyltransferase 3 (inactive)
Chromosome
4
Location
4q21.1
TaxID
9606
Status
live
SourceGenome
genomic
SourceOrigin
natural
CreationDate
1998-05-11
ModificationDate
2021-06-11
Ontological Relatives
UniProt IDs
NAR3_HUMAN
GO terms
Show/Hide Table
GO
Name
GO:0003950
NAD+ ADP-ribosyltransferase activity
GO:0005576
extracellular region
GO:0005886
plasma membrane
GO:0006471
protein ADP-ribosylation
GO:0018120
peptidyl-arginine ADP-ribosylation
GO:0031225
anchored component of membrane
GO:0031226
intrinsic component of plasma membrane
GO:0070062
extracellular exosome
GO:0106274
NAD+-protein-arginine ADP-ribosyltransferase activity
GO:0106275
NADP+-protein-arginine ADP-ribosyltransferase activity
Diseases
Show/Hide Table
Interactions
25 interactions
Interactor
Partner
Sources
Publications
Link
ART3
ALCAM
BioGRID, IntAct
21988832
details
ART3
PRKCD
BioGRID
20395553
details
ART3
TEX101
BioGRID, UniProt
30097533
details
ART3
MDN1
BioGRID
26186194
details
ART3
ATP12A
BioGRID
26186194
28514442
details
ART3
PIGO
BioGRID
26186194
details
ART3
RAB39B
BioGRID
26186194
details
ART3
DDX19B
BioGRID
26186194
details
ART3
CHD1L
BioGRID
26186194
details
ART3
DYNC2LI1
BioGRID
26186194
details
ART3
PAM
BioGRID
26186194
28514442
details
ART3
NAGLU
BioGRID
26186194
28514442
details
ART3
ARSK
BioGRID
26186194
28514442
details
ART3
HSPA12A
BioGRID
26186194
28514442
details
ART3
GPD1L
BioGRID
26186194
details
ART3
ITGA7
BioGRID
26186194
details
ART3
MGAT5
BioGRID
26186194
details
ART3
CBWD3
BioGRID
26186194
28514442
details
ART3
POGLUT1
BioGRID
26186194
28514442
details
ART3
SPG7
BioGRID
26186194
details
ART3
PSEN2
BioGRID
26186194
details
ART3
MAP2K2
BioGRID
26186194
details
ART3
SCAMP2
BioGRID
26186194
details
ART3
GALNT7
BioGRID
26186194
details
ART3
ITGA8
BioGRID
26186194
28514442
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree